1Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens- Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no TENefit on mortality or progression. Arch Dermol 2003 ; 139 ( 1 ) : 33 - 36.
2Beurgdorf WHC, Plewig G, Wolf HH, et al. Severe cutaneous adverse reactions [ J ]. Braun - Falco's Dermatology, 2008,3 : 473-483.
